Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

Efficacy of epoetin alfa in the treatment of anaemia of multiple myeloma.

Dammacco F, Castoldi G, Rödjer S.

Br J Haematol. 2001 Apr;113(1):172-9. Erratum in: Br J Haematol 2001 Sep;114(3):738.

PMID:
11328297
2.

Epoetin alfa corrects anemia and improves quality of life in patients with hematologic malignancies receiving non-platinum chemotherapy.

Littlewood TJ, Nortier J, Rapoport B, Pawlicki M, de Wasch G, Vercammen E, Schuette W, Wils J, Freund M; Epoetin Alfa Study Group..

Hematol Oncol. 2003 Dec;21(4):169-80.

PMID:
14735555
3.

Epoetin alfa maintains ribavirin dose in HCV-infected patients: a prospective, double-blind, randomized controlled study.

Afdhal NH, Dieterich DT, Pockros PJ, Schiff ER, Shiffman ML, Sulkowski MS, Wright T, Younossi Z, Goon BL, Tang KL, Bowers PJ; Proactive Study Group..

Gastroenterology. 2004 May;126(5):1302-11.

PMID:
15131791
4.

Once-weekly dose of epoetinum alfa in cancer patients with anemia receiving radiotherapy.

Ots PM, Pérez AR, Carrizosa CL, Ocaña CV, de Dios Sáez Garrido J, Delgado Pérez JM.

Clin Transl Oncol. 2005 Dec;7(11):486-92.

PMID:
16373059
5.

Effectiveness and safety of an induction therapy with epoetin alfa in anemic cancer patients receiving concomitant chemotherapy.

Cortesi E, Mancuso A, De Pasquale Ceratti A, Pizzardi N, D'Auria G, Accettura C, Beccaglia P, Bertelletti D, De Marinis F.

Oncologist. 2004;9(4):459-68.

6.

Phase III, randomized, double-blind study of epoetin alfa compared with placebo in anemic patients receiving chemotherapy.

Witzig TE, Silberstein PT, Loprinzi CL, Sloan JA, Novotny PJ, Mailliard JA, Rowland KM, Alberts SR, Krook JE, Levitt R, Morton RF.

J Clin Oncol. 2005 Apr 20;23(12):2606-17.

PMID:
15452187
7.

Weekly epoetin alfa during adjuvant chemotherapy for breast cancer: effect on hemoglobin levels and quality of life.

Hudis CA, Vogel CL, Gralow JR, Williams D; Procrit Study Group..

Clin Breast Cancer. 2005 Jun;6(2):132-42.

PMID:
16001991
8.

Once-weekly epoetin alfa for treating the anemia of chronic kidney disease.

Provenzano R, Garcia-Mayol L, Suchinda P, Von Hartitzsch B, Woollen SB, Zabaneh R, Fink JC; POWER Study Group..

Clin Nephrol. 2004 Jun;61(6):392-405.

PMID:
15224803
10.

Chronic anemia and fatigue in elderly patients: results of a randomized, double-blind, placebo-controlled, crossover exploratory study with epoetin alfa.

Agnihotri P, Telfer M, Butt Z, Jella A, Cella D, Kozma CM, Ahuja M, Riaz S, Akamah J.

J Am Geriatr Soc. 2007 Oct;55(10):1557-65.

PMID:
17697104
11.

Extended epoetin alfa dosing as maintenance treatment for the anemia of chronic kidney disease: the PROMPT study.

Provenzano R, Bhaduri S, Singh AK; PROMPT Study Group..

Clin Nephrol. 2005 Aug;64(2):113-23.

PMID:
16114787
12.

Comparison of the therapeutic effects of epoetin zeta to epoetin alfa in the maintenance phase of renal anaemia treatment.

Wizemann V, Rutkowski B, Baldamus C, Scigalla P, Koytchev R; Epoetin Zeta Study Group..

Curr Med Res Opin. 2008 Mar;24(3):625-37. doi: 10.1185/030079908X273264. Erratum in: Curr Med Res Opin. 2008 Oct;24(10):3007. Curr Med Res Opin. 2008 Apr;24(4):1155.

PMID:
18208642
13.

Comparing the efficacy and safety of fixed versus weight-based dosing of epoetin alpha in anemic cancer patients receiving platinum-based chemotherapy.

Granetto C, Ricci S, Martoni A, Pezzella G, Testore F, Mattioli R, Lampignano M, Tacconi F, Porrozzi S, Gasparini G, Mantovani G; EPO-ITA3 Study Group..

Oncol Rep. 2003 Sep-Oct;10(5):1289-96.

PMID:
12883695
14.

Antianemic effect of once weekly regimen of epoetin alfa 40,000 units in anemic cancer patients receiving chemotherapy.

Voravud N, Sriuranpong V, Suwanrusme H.

J Med Assoc Thai. 2007 Jun;90(6):1082-8.

PMID:
17624200
15.

Epoetin alfa for the treatment of the anemia of multiple myeloma. A prospective, randomized, placebo-controlled, double-blind trial.

Garton JP, Gertz MA, Witzig TE, Greipp PR, Lust JA, Schroeder G, Kyle RA.

Arch Intern Med. 1995 Oct 23;155(19):2069-74.

PMID:
7575066
16.

Anaemia management with epoetin alfa in lung cancer patients in The Netherlands.

Biesma B, van de Werf PR, Melissant CF, Brok RG.

Lung Cancer. 2007 Oct;58(1):104-11.

PMID:
17601632
17.

Epoetin alfa 60,000 U once weekly followed by 120,000 U every 3 weeks increases and maintains hemoglobin levels in anemic cancer patients undergoing chemotherapy.

Patton J, Kuzur M, Liggett W, Miranda F, Varsos H, Porter L.

Oncologist. 2004;9(1):90-6. Erratum in: Oncologist. 2004;9(2):240.

18.
19.

Correlation between variation in quality of life and change in hemoglobin level after treatment with epoetin alfa 40,000 IU administered once-weekly.

Cartenì G, Giannetta L, Ucci G, De Signoribus G, Vecchione A, Pinotti G, Puglisi F, Contillo A, Pezzella G, Orecchia S, Beccaglia P; OBI/EPO-ITA-01/1 study group..

Support Care Cancer. 2007 Sep;15(9):1057-66.

PMID:
17431689
20.

Pharmacokinetics and pharmacodynamics of once-weekly subcutaneous epoetin alfa in critically ill patients: results of a randomized, double-blind, placebo-controlled trial.

Vincent JL, Spapen HD, Creteur J, Piagnerelli M, Hubloue I, Diltoer M, Roman A, Stevens E, Vercammen E, Beaver JS.

Crit Care Med. 2006 Jun;34(6):1661-7.

PMID:
16607233

Supplemental Content

Support Center